This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
No Items In Cart
China has now stepped into its “golden age” of biopharma; this year regulators approved the country’s first biosimilar product, HLX01. Developed by Shanghai Henlius Biotech, it will be used primarily for treatment of non-Hodgkin’s lymphoma. Biologics are sensitive large molecules, so selecting the appropriate packaging and delivery system is critical. To this end, West Pharmaceutical Services, Inc. (“West”) recently held China BioPharma Summit for Injectable Drug Packaging and Delivery Systems in Suzhou. Over 200 persons attended.
A broad range of topics were discussed by speakers from West, Daikyo Seiko, Ltd., China National Pharmaceutical Packaging Association (CNPPA), Shanghai Food and Drug Packaging Materials Control Center, Shanghai Henlius Biotech, Wuxi Biologics, and GBI. Highlights included:
West is committed to staying abreast of world-wide drug product developments and supporting customers in getting the right packaging and delivery systems for their products. For more on West, contact an Account Manager or Technical Customer Support (TCS) representative.
Take an in-depth look at the science behind containment & delivery of injectable medicines in the West Knowledge Center.